Radiopharmaceutical Validation for Clinical Use

Overview of attention for article published in Frontiers in oncology, March 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,639 followers.

RT @AmanChauhanMD: Radioligand Therapies (RLT) are reemerging as attractive anticancer agents. In this article, we discuss four levels of e…

27 Mar 2021

Reply Repost Favourite

RT @AmanChauhanMD: Radioligand Therapies (RLT) are reemerging as attractive anticancer agents. In this article, we discuss four levels of e…

20 Mar 2021

Reply Repost Favourite

Radioligand Therapies (RLT) are reemerging as attractive anticancer agents. In this article, we discuss four levels of evidence and procedures for evaluating agent validity before early-phase clinical trial. @UKMarkey ⁦ ⁦@UK_HealthCare⁩ https://t.co/PzDjn

20 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.